• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Quintiles’ Singapore Operations to Double in 2009

Quintiles’ Singapore Operations to Double in 2009

September 22, 2008
CenterWatch Staff

Contract-research organization (CRO) Quintiles is doubling the size of its Singapore operations, an expansion that will produce Asia-Pacific’s largest clinical development organization, according to the company.

The Research Triangle Park, N.C.-based CRO currently occupies close to 40,000 square feet of space in three locations in Singapore, but, in late 2009, Quintiles Central Laboratory and Clinical Development Services offices will relocate to an 80,000-square-foot space in the Cintech IV building now under construction in Singapore’s Science Park One. “We are projecting continued strong growth [in Singapore], and this new facility gives us the room we will need,” said Anand Tharmaratnam, M.D., head of clinical development for Quintiles Asia Pacific. “The new location also will allow us to work more efficiently, share best practices and deliver truly turnkey solutions to our customers.” The new space will hold about 400 employees, almost double the 225 employees now in Singapore.

“We continue to invest in new talent in Singapore, and we are also adding new delivery and corporate functions in Singapore so our headcount numbers are continually growing,” said Tharmaratnam. Singapore has emerged as a leader for early-stage clinical trials outsourcing in the past decade.

Quintiles’ Asia-Pacific presence has grown rapidly since the CRO entered the region in 1993 with offices in Japan and Australia. Since establishing its Singapore offices in 1995, Quintiles has conducted more than 1,000 studies involving more than 6,000 sites and 160,000 patients in the region. As the home of the CRO’s regional headquarters, Singapore holds many advantages for the company, Tharmaratnam said.

“Firstly, a significant proportion of our customers are in Singapore and all of them are within a seven-hour direct flight from Singapore. Singapore is also connected by direct flights to a lot of our U.S. and European offices,” he said. “Secondly, we are able to hire talent with multinational company experience in Singapore, and we are able to attract foreign talent to relocate to Singapore who find it a stable, secure and welcoming environment to live in as a foreigner. Thirdly, it is an attractive place from which to manage a business with very high ethical and transparent governance standards with an effective tax structure. Fourth, it is increasingly becoming a global hub for scientific excellence and innovation.”

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing